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SUMMARY
1. The adenosine analogue 2-chloroadenosine (CADO) reduced the duration of
calcium-dependent action potentials (CAPs) in mouse dorsal root ganglion (DRG)
neurones in culture, by reducing voltage-activated calcium conductance (Macdonald,
Skerritt & Werz, 1986). Using the single-electrode voltage clamp technique, we
recorded three calcium current components in these neurones, the transient low-
threshold (T), transient high-threshold (N) and slowly inactivating high-threshold
(L) currents, as described previously (Nowycky, Fox & Tsien, 1985; Gross &
Macdonald, 1987). CADO (100 /1M) had no effect on the isolated T and L currents. In
contrast, CADO reduced calcium currents evoked at clamp potentials positive to
-20 mV from holding potentials (Vh) near the resting membrane potential; under
these conditions, the calcium current consisted primarily ofN and L calcium current
components.
2. This effect ofCADO was not voltage dependent. CADO reduced the magnitude
of the calcium current without affecting the voltage dependence of the calcium
current-voltage relation. In addition, similar reductions of calcium current were
observed when currents were evoked from Vh of -60 or -80 mV.
3. In order to determine if a guanine nucleotide-binding (G) protein was involved
in the CADO effect on calcium current, cultures were pre-treated with pertussis toxin
(PT) for at least four hours. PT (100 ng/ml) reduced or abolished the CADO-induced
reduction of CAP duration and calcium current.
4. Since CADO inhibits adenylate cyclase through the PT-sensitive G protein,
Gi, we compared the effects ofCADO and 8-Br-adenosine 3',5'-cyclic-monophosphate
(8-Br-cyclic AMP) on calcium current. The effect of 8-Br-cyclic AMP was voltage
dependent, unlike that of CADO. 8-Br-cyclic AMP reduced calcium currents evoked
from Vh = -65 mV, but had no effect on currents evoked from Vh = -85 mV.
5. We conclude that the adenosine agonist CADO reduced CAP duration in mouse
DRG neurones by selectively reducing the N current component, and that the
coupling between the adenosine receptor and the calcium channel required a PT-
sensitive G protein. The CADO effect was unlikely, however, to be due to modulation
of adenylate cyclase activity.
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INTRODUCTION
Adenosine and the adenine nucleotides probably act as neurotransmitters in the
peripheral and central nervous systems (e.g. Phillis & Wu, 1981; Williams, 1987).
These substances are usually inhibitory and have been shown to reduce neuro-
transmitter release in a number of different preparations (e.g. Dunwiddie &
Fredholm, 1984; Singh, Dryden & Chen, 1986). Adenosine and its analogues also
have been shown to inhibit synaptosomal calcium influx (Wu, Phillis & Thierry,
1982) and to decrease the duration of calcium-dependent action potentials (CAPs)
and the magnitude of voltage-activated calcium currents (Henon & McAfee, 1983;
Macdonald et al. 1986; Dolphin, Forda & Scott, 1986). These observations are
consistent with the idea that adenosine reduces neurotransmission through
modulation of calcium current.
It has recently been shown, however, that multiple voltage-activated calcium
current components exist in neurones (Nowycky et al. 1985; Fox, Nowycky & Tsien,
1987a, b; Gross & Macdonald, 1987), the transient low-threshold (T), the slowly
inactivating high-threshold (L) and the transient high-threshold (N) calcium current
components. It has not yet been determined which of these current components is
affected by adenosine, or by what biophysical or biochemical mechanism(s).
Neurotransmitter receptors could be coupled directly to ion channels via G
proteins, or indirectly, via second messenger systems. Recently G proteins have been
demonstrated to regulate neurotransmitter modulation of potassium (Breitwieser &
Szabo, 1985; Pfaffinger, Martin, Hunter, Nathanson & Hille, 1985) and calcium
currents (Holz, Rane & Dunlap, 1986; Heschler, Rosenthal, Trautwein & Schultz,
1987). In addition, G protein involvement in adenosine agonist-induced inhibition of
calcium current has been demonstrated utilizing non-hydrolysable GTP analogues;
intracellular administration of GTP-y-S enhanced, while GDP-,i-S reduced, the
adenosine effect (Scott & Dolphin, 1987). Adenosine has also been shown to inhibit
or stimulate adenylate cyclase activity, presumably via Gi or G,s (Gilman, 1984), by
binding to A1 or A2 receptors, respectively (Fredholm, Jonzon & Lindstrom, 1983).
Previous work (Macdonald et al. 1986; Dolphin et al. 1986) suggested that the
reduction of calcium current by adenosine was mediated through receptors that were
most similar to the A1 type. Thus, it is possible that adenosine could modify calcium
channel activity directly via G proteins or indirectly by modulating cyclic AMP
levels.
We therefore tested the effect of the adenosine analogue 2-chloroadenosine
(CADO) on the T, L and N current components in mouse dorsal root ganglion (DRG)
neurones in culture. The role of a G protein in regulating adenosine receptor-
mediated effects on calcium currents was assessed using pertussis toxin (PT), an
exotoxin from Bordetella pertussis, which inactivates Gi and G. (Gilman, 1984;
Hescheler et al. 1987). We also compared the effects of CADO and 8-Br-cyclic AMP
to determine if the adenylate cyclase-cyclic AMP second messenger system was
involved in the CADO-induced reduction of calcium current.
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METHODS
Cell culture
Fetal DRG neuronies were grown in culture with spinal cord neurones as previously described
(Gross & Macdonald, 1987), except that the concentration of nerve growth factor in the plating
medium was 100-500 ng/ml, and 10-200 ng/ml thereafter. Cultures were used for experiments
after 4-12 weeks.
Intracellular recording of action potentials and single-electrode voltage clamp
Intracellular recordings were made at 35 °C in a recording solution of pH 7 3-7 4 and 320 mosm
consisting of the following (in mM): NaCl, 142-4; KCI, 5-3; CaCl2, 50; MgCl2, 0-8; glucose, 5-6; Tris-
base, 13-0; tetraethylammonium chloride (TEA-Cl), 5 0. Recording micropipettes (20-40 MQ) were
filled with 4 M-potassium acetate. Action potentials were recorded as previously described
(Macdonald et al. 1986). Action potential duration was measured from the stimulus onset to the
time when the original membrane potential was restored. After-hyperpolarizations were not
included in the duration measurement.
For voltage clamp experiments recording micropipettes were filled with 3 M-CsCl. The recording
solution consisted of the following (in mM): Tris-base, 13; choline chloride, 67; KCI, 5 0; CaCl2, 2-0;
MgCl2, 0-8; glucose, 5-6; TEA-Cl, 100, at a pH of 7 3-7-4 and osmolarity of 320 mosm. Injection of
the potassium channel blocker caesium into neurones from the recording micropipette and use of
sodium-free, TEA-containing recording solution allowed recording of calcium currents virtually
free of potassium or sodium currents. A single-electrode voltage clamp amplifier (Axoclamp-2,
Axon Instruments, Burlingame, CA, USA) was used which switched between voltage sampling and
current injection at 8-10 kHz with a 70% (recording)-30 % (current injection) duty cycle.
Headstage outputs were continuously monitored on a separate oscilloscope to ensure that voltage
settling occurred prior to the voltage sample-and-hold measurement. Voltage step commands were
generated by a microcomputer (IBM-XT) using the program pClamp (Axon Instruments, La Jolla,
CA, USA). Current traces were sampled at 1-6-5-0 kHz, depending on the duration of the voltage
step command (512 samples per sweep), and digitized, stored and analysed using this same
program.
Leak currents were determined by applying hyperpolarizing voltage commands of magnitudes
equal to the depolarizing commands used to evoke the inward currents being studied. These
hyperpolarizing commands produced inward currents which were assumed to be equal and opposite
in magnitude to leak currents. Alternatively, leak currents were recorded during depolarizing
commands equivalent to those used to evoke inward currents after block of calcium currents by
cadmium (100-200 /LM). In either case, leak currents were subtracted digitally from the relevant
inward currents to yield the calcium currents.
Voltage clamp recordings were made from neurones 40-50 #tm in diameter. To obtain the best
possible voltage clamp, neurones were selected that were nearly spherical and without large
processes. If poor voltage clamp control occurred, currents were not included in the analyses.
Drug preparation and application
CADO (100 aM) and 8-Br-cyclic AMP (1 mM; both from Sigma Chemical Co., St Louis, MO, USA)
were dissolved in recording medium and applied by pressure ejection (1-68-6-7 kPa) from
micropipettes with tip diameters of 10-15 /tm. Drug- or diluent-containing micropipettes were
positioned approximately 20 ,um from the cell body during the 1-2 s application, then removed to
the oil phase. Micropipettes containing diluent had no effect on evoked action potentials, currents
or holding currents. A concentration of 100 ,#M-CADO was used as this concentration was
previously determined to elicit a maximum response (Macdonald et al. 1986).
Pertussis toxin pre-incubation
For some experiments neurones were pre-incubated with PT (Sigma Chemical Co.). Four
microlitres of 50 ,tg/ml pertussis toxin in 0-1 % bovine serum albumin (BSA) was added to neuronal
cultures containing 2 ml of culture medium resulting in a concentration of 100 ng/ml PT. Control
cultures received 4 1d of 0-1% BSA. Cultures were incubated for 4-16 h. Prior to intracellular
recording, culture medium was exchanged for recording medium containing 100 ng/ml PT or
diluent. Comparisons were made between treated and untreated cultures of the same plating.
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Alternatively, the position of each neurone was marked following recording. The recording medium
was then exchanged for growth medium plus PT or diluent as described above and the neurones
were incubated 16-20 h. Each neurone was then relocated, and recordings made following
reimpalement.
Statistics
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Fig. 1. CADO selectively reduced N current. The currents shown in A and C were recorded
from the same neurone while those in B are from a different neurone. Illustrative voltage
traces show the Vh and voltage step (mV). Digitized, leak-subtracted currents are shown;
inward traces are downward. Current traces were obtained before (trace 1), immediately
after (trace 2), and following recovery from (trace 3) application of 100 /#M-CADO. The
isolated T (A) and L (B) currents were unaffected by CADO. The peak calcium current was
selectively reduced by CADO, suggesting an action on N current alone (C). Note in tracing
A that the T current did not decay to the baseline. This was probably due to an
overestimate of leak current or may reflect long-lasting T-type channel openings (Fox et
al. 1987).
RESULTS
2-Chloroadenosine selectively reduced the N current in dorsal root ganglion neurones
The first series of experiments tested whether the CADO-induced reduction of
voltage-activated calcium conductance in DRG neurones was due to a differential
effect on the three calcium current components of these neurones. In the present
studies, the isolated T current was 10-1 5 nA when evoked at -60 to -50 mV from
Vh = -90 to -100 mV, and the isolated L current was 1 0 to 3-0 nA when evoked at
-20 to 0 mV from Vh = -50 to -40 mV. The N and L current components were
evoked together with commands positive to -20 mV from Vh = -65 mV. Using this
protocol the N current component was estimated to be 5-15 nA (Fig. 1).
CADO (100 ,sM) had no effect on the isolated T (Fig. 1A) or L (Fig. 1B) currents.
In contrast, CADO reduced the peak calcium current evoked positive to -20 mV
from Vh near the resting membrane potential. There was a wide variability in the
response rate and the extent of calcium current reduction among culture groups. In
a typical culture group, CADO reduced the peak calcium current 10-38% (Fig. 1 C)
in twenty-two out of twenty-five neurones, with the mean reduction being 21 + 2%
(± S.E.M., n = 22). This effect ofCADO was rapid in onset (within 5 s) and completely
reversed in 1-3 min (Fig. I C).
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This laboratory has previously demonstrated that CADO reduced calcium currents
evoked at potentials positive to -50 mV and had no effect on the voltage
dependence of the calcium current-voltage relation (Macdonald et al. 1986). This
observation was confirmed in the present study in three neurones in which
commands were applied from Vh = -80 mV in the presence and absence of 100 /M-
CADO (data not shown). In addition, CADO reduced peak calcium current to a
similar extent whether currents were evoked at -20 mV from Vh = -80 or -60 mV.
Pertussis toxin pre-incubation prevented the 2-chloroadenosine-induced reduction of
calcium-dependent action potential duration
Previous work in this laboratory has established that the CADO-induced reduction
of CAP duration was due to a decrease in calcium current (Macdonald et al. 1986).
Because the responsiveness of the neurones to CADO varied among culture lots, we
used CAP duration as an assay of the responsiveness of culture groups to CADO. This
technique allowed large numbers of neurones to be sampled, and was therefore
employed in the initial experiments testing the effect ofPT pre-incubation on CADO
responses.
Two experiments were done to test the effect of CADO (100 /LM) on CAP duration
following pre-incubation of DRG neurones with PT. In the first experiment, paired
cultures from the same plating were treated with 100 ng/ml PT or control medium
for 4 or 16 h, and the effect of CADO on CAP duration was determined. In control
cultures from the 4 h treatment protocol, thirteen of twenty-three (57 %) neurones
responded to CADO with a mean decrease in CAP duration of 30+ 5% (+ S.E.M.). In
the cultures treated for 4 h with PT only seven of twenty-four (29%) neurones
responded to CADO with a mean reduction in CAP duration of 20+ 6% (+s.E.M.).
In control cultures from the 16 h treatment protocol, forty-five of sixty-nine (65 %)
neurones responded to CADO with a mean reduction in the CAP duration of 36+ 3%
(+S.E.M.). In cultures treated with PT for 16 h, none of the thirty-three neurones
tested responded to CADO with a reduction in CAP duration.
In a second experiment, thirty DRG neurones in which CADO (100 /M) elicited a
reduction in CAP duration were identified, and their positions in the culture dish
were marked as described in Methods. These DRG neurones were then treated with
100 ng/ml PT or control medium for 4 or 16 h. Of these neurones, three control and
five PT-treated neurones were viable following treatment. The neurones were then
reimpaled and CAPs evoked. The CADO-induced reduction in CAP duration which
ranged from 20 to 40% in control neurones was unchanged following reimpalement
(Fig. 2A). The CADO-elicited decrease in CAP duration was reduced from 57 to 20%,
a 65% reduction, in a neurone treated for 4 h with PT. In four neurones in which the
CADO-elicited decrease in CAP duration ranged from 10 to 28%, CADO no longer
elicited a decrease in CAP duration following 16 h of PT treatment (Fig. 2B).
Pertussis toxin prevented the 2-chloroadenosine-elicited reduction of calcium current
After establishing that PT pre-treatment blocked the CADO-elicited reduction of
CAP duration, we used the voltage clamp technique to test if PT pre-treatment
blocked the CADO-elicited reduction of calcium current. Paired cultures from the
same plating were treated with 100 ng/ml PT or control medium for 7 or 16 h.
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Fig. 2. PT pre-treatment blocked the CADO-induced reduction in CAP duration. CAPs
were evoked every 15 s prior to (trace 1) and subsequent to (trace 2) application of
100 /SM-CADO. A, CAPs recorded from the same neurone before (day 1) and after (day 2)
a 16 h treatment with control medium. B, CAPs were recorded from a different neurone
before (day 1) and after (day 2) a 16 h treatment with PT-containing (100 ng/ml)
medium. PT treatment blocked the ability of CADO to reduce the CAP duration. The









Fig. 3. PT blocked CADO-elicited reduction of calcium current. Digitized, leak-subtracted
currents from two neurones are shown. Currents are shown before (trace 1) and after
(trace 2) a 2 s pressure ejection of CADO (100 /LM). CADO reduced calcium current in a
neurone treated for 16 h with control medium (A) but had no effect on calcium current in
a neurone treated for 16 h with 100 ng/ml PT (B).
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Fig. 4. CADO reduced peak calcium current in a voltage-independent manner while 8-Br-
cyclic AMP reduced peak calcium current in a voltage-dependent manner. The currents
shown in Aa and b are from the same neurone while those in Ba and b are from two
different neurones. Digitized, leak-subtracted currents are shown. Currents are shown
before (trace 1) and after (trace 2) a 2 s pressure ejection of CADO (100 /tM; A) or 8-Br-
cyclic AMP (1 mM; B). CADO reduced peak calcium current equally when evoked from
Vh= -60 mV (Aa) or -80 mV (Ab). 8-Br-cyclic AMP reduced peak calcium current when
evoked from Vh= -65 mV (Ba) but not from Vh = -85 mV (Bb).
Calcium currents were evoked with 300 ms depolarizing commands to -5 mV from
Vh = -65 mV. In PT-treated neurones, the reduction of peak calcium current by
100 /tM-CADO was less than that in control neurones (Fig. 3). CADO reduced peak
calcium current in control neurones 22+2% (+ S.E.M., n = 14) and PT-treated
neurones 7+2% (±S.E.M., n = 15; significantly different from control, P < 005).
The reduction in peak calcium current induced by CADO in PT-treated cells was not
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8-Br-Cyclic AMP reduced peak calcium current in a voltage-dependent manner
The above experiments showed that a PT-sensitive G protein was required to
mediate the reduction of N current by CADO. One possible pathway would be
through Gi-mediated inhibition of adenylate cyclase. If this were the case, it would
be expected that an increase in cyclic AMP would have the opposite effect of CADO.
To test this, we compared the effect ofCADO to that of 8-Br-cyclic AMP on calcium
currents in DRG neurones.
CADO (100 fM) reduced peak calcium current to a similar extent when evoked at
-20 mV from Vh=-60 or -80 mV, 21 + 2% (n = 22) and 19+ 3% (n = 5),
respectively (Fig. 4A). In contrast, 8-Br-cyclic AMP reduced peak calcium current
24+6% (n = 4) when evoked at -15 mV from Vh= -65 (Fig. 4Ba) but had no
effect on currents evoked from Vh= -80 (n = 10, Fig. 4Bb). The reduction of
calcium current evoked from Vh = -65 mV was maximal 3-5 min after the
application of 8-Br-cyclic AMP.
DISCUSSION
The present study confirms and extends the previous report that CADO shortened
CAP duration and reduced a voltage-dependent calcium conductance in mouse DRG
neurones (Macdonald et al. 1986). CADO had no effect on isolated T or L currents,
but reduced calcium currents containing the N current component, suggesting that
its effect was due to a selective reduction of the N current. A similar effect of CADO
in hippocampal CA3 neurones has been reported in preliminary form by Madison and
his colleagues (1987). CADO did not alter the voltage dependence of the calcium
current-voltage relation, the apparent time dependence of current activation, or the
rate of N current inactivation. In addition, the peak calcium current was reduced to
a similar degree by CADO when neurones were held at Vh= -60 to -80 mV,
suggesting that CADO did not alter the voltage dependence of steady-state
inactivation of N current. It is nevertheless possible that CADO reduced calcium
currents by increasing steady-state inactivation, i.e. by causing a negative shift in
the steady-state inactivation curve. This shift would have been greater than
-15 mV to account for the similarity in current reduction at Vh of -65 and -80 mV,
however. Clearly, further experiments will be needed, perhaps including single-
channel current analysis, to unequivocally determine the biophysical mechanism of
calcium current reduction by CADO.
Previous work has demonstrated the involvement of a G protein in the CADO-
induced inhibition of cortical neurones (O'Regan & Phillis, 1987) and the reduction
of calcium current (Scott & Dolphin, 1987). The present studies confirm and extend
these observations by showing that the selective effect of CADO on calcium current
components was mediated through a PT-sensitive G protein. PT ADP-ribosylates
both Gi, which links neurotransmitter receptors to adenylate cyclase in an inhibitory
manner, and GO, a neuronal G protein recently shown to link neurotransmitter
receptors to calcium channels (Hescheler et al. 1987). PT renders Gi non-functional
and has a similar effect on Go (Gilman 1984; Sternweis & Robishaw, 1984; Ewald,
Sternweis & Miller, 1988). Either of these G proteins could, therefore, potentially
mediate the effect of CADO on N current.
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If Gi mediated the CADO-induced reduction of calcium current, than it could do
so by inhibiting adenylate cyclase and reducing cyclic AMP levels. We consider this
to be unlikely, however, since the action of 8-Br-cyclic AMP on calcium current was
similar, rather than opposite, to that of CADO. Furthermore, while 8-Br-cyclic AMP
also reduced N current selectively (Gross & Macdonald, 1988, 1989), it apparently did
so by a mechanism different to that of CADO - the reduction of N current by 8-Br-
cyclic AMP was voltage dependent while the reduction produced by CADO was not.
These results are consistent with the idea that the reduction of N current by CADO
may be mediated by Gi, and presumably by associated A1 receptors, but that this
effect was probably not mediated by modulation of cyclic AMP levels (cf. Dunwiddie
& Fredholm, 1984).
Alternatively, a PT-sensitive G protein could link the adenosine receptor directly
to the calcium channel. This type of mechanism has been described for the coupling
of adenosine and cholinergic receptors to potassium channels (Kurachi, Nakajima &
Sugimoto, 1986; Yantani, Codina, Brown & Birnbaumer, 1987). G proteins also
couple a variety of transmitter receptors to calcium channels (e.g. Dolphin &
Prestwich, 1985; Holz, Rane & Dunlap, 1986; Hescheler et al. 1987; Wanke, Ferroni,
Malgaroli, Ambrosini, Pozzan & Meldolesi, 1987; Ewald et al. 1988). Further study
will be required to determine the identity of and the mechanism by which the G
protein mediates the CADO-induced reduction of N current.
The reduction of N current by adenosine could have important short- and long-
term effects on neuronal function. Voltage-activated calcium channels not only
contribute to neuronal depolarization, but allow the influx of calcium which can, in
turn, activate potassium conductance (Meech, 1978), activate second messenger
system components (Berridge & Irvine, 1985; Johnson & Mills, 1986) and initiate
neurotransmitter release.
Thus, the reduction of N current by adenosine or its analogues could reduce
neuronal excitability and modify other calcium-dependent neuronal processes. Of
interest in this regard are other reports demonstrating effects of other compounds on
N-type currents, including the neurotransmitters acetylcholine (Wanke et al. 1987),
dynorphin A (Gross & Macdonald, 1987), neuropeptide Y (Ewald et al. 1988; Wiley,
Gross, Fox & Macdonald, 1988), noradrenaline acting at x-receptors (Lipscombe &
Tsien, 1987), and activators of second messenger systems (Gross & Macdonald,
1988, 1989). Furthermore, N current has recently been demonstrated to have a
dominant role in evoked release of noradrenaline from sympathetic neurones
(Hirning, Fox, McCleskey, Olivera, Thayer, Miller & Tsien, 1988). Adenosine inhibits
the release of a variety of neurotransmitters from neuronal preparations (Fredholm
& Hedqvist, 1980; Hollins & Stone, 1980; Phillis & Wu, 1981), an effect that has been
shown to be blocked by PT in cerebellar and cortical neurones (Dolphin & Prestwich,
1985; Fredholm, Fastbom & Lindgren, 1986). As N current is the predominant
calcium current in DRG neurones, our data would be consistent with the proposal
that adenosine reduces neurotransmitter release through a reduction of N current
that is mediated by a PT-sensitive G protein.
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